Chapter 1 Methodology and Scope
1.1. Research method
1.2. Research scope and prerequisites
Chapter 2 Executive Summary
Chapter 3. Global Cannabidiol (CBD) API Market Snapshot
Chapter 4. Global Cannabidiol (CBD) API Market Variables, Trends and Scope
4.1. Market Segmentation and Scope
4.2.Driver
4.3. Challenges
4.4.Trend
4.5.Investment and Fund Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7.Competitive environment and market share analysis
4.8. Impact of new coronavirus infection analysis
Chapter 5 Market Segmentation 1: By Origin, Estimation and Trend Analysis
5.1. By Region of Origin and Market Share, 2019 and 2031
5.2. Market size (USD Million), forecast and trend analysis from 2019 to 2031:
5.2.1.Nature
5.2.2.Synthesis
Chapter 6 Market Segmentation 2: Estimation and Trend Analysis by Product
6.1. By Product and Market Share, 2019 and 2031
6.2. Market size (amount in million USD), forecast and trend analysis, by product, 2019-2031:
6.2.1. Full Spectrum CBD
6.2.2. Broad Spectrum CBD
6.2.3. CBD isolate
6.2.4. Water-dispersible CBD powder
6.2.5.Other products
Chapter 7 Market Segmentation 3: Estimation and Trend Analysis by Indication
7.1. By Indication and Market Share, 2019 and 2031
7.2. Market size (amount USD million), forecast and trend analysis, by indications, 2019-2031:
7.2.1.Alzheimer's disease
7.2.2. Autism
7.2.3. Cancer
7.2.4. Chronic pain
7.2.5. Epilepsy
7.2.6. Migraine
7.2.7.Multiple Sclerosis
7.2.8.Schizophrenia
7.2.9.Other indications
Chapter 8 Market Segmentation 4: End User Estimation and Trend Analysis
8.1. By End User and Market Share, 2019 and 2031
8.2. Following Market Size (Value USD Million) by End User, Forecast and Trend Analysis, 2019-2031:
8.2.1.Pharmaceutical industry
8.2.2. Academic and clinical research institutions
Chapter 9 Cannabidiol (CBD) API Market Segmentation 5: Regional Estimation and Trend Analysis
9.1. North America
9.1.1. North America Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast by Origin, 2024-2031
9.1.2. North America Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast by Product, 2024-2031
9.1.3. North America Cannabidiol (CBD) API Market Revenue (Million USD) Estimated and Forecast by Indication, 2024-2031
9.1.4. North America Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast by End User, 2024-2031
9.1.5. North America Cannabidiol (CBD) API Market Revenue (USD Million) Estimates and Forecast by Country, 2024-2031
9.2.Europe
9.2.1.Europe Cannabidiol (CBD) API Market Revenue (USD Million) by Origin, 2024-2031
9.2.2.Europe Cannabidiol (CBD) API Market Revenue (USD Million) by Product, 2024-2031
9.2.3.Europe Cannabidiol (CBD) API Market Revenue (USD Million) by Indication, 2024-2031
9.2.4.Europe Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast, by End User, 2024-2031
9.2.5.Europe Cannabidiol (CBD) API Market Revenue by Countries (USD Million), 2024-2031
9.3.Asia Pacific region
9.3.1. Asia Pacific Cannabidiol (CBD) API Market Revenue (USD Million) by Origin, 2024-2031
9.3.2.Asia Pacific Cannabidiol (CBD) API Market Revenue (USD Million) by Product, 2024-2031
9.3.3.Asia Pacific Cannabidiol (CBD) API Market Revenue (USD Million) by Indication, 2024-2031
9.3.4. Asia Pacific Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast, by End User, 2024-2031
9.3.5.Asia Pacific Cannabidiol (CBD) API Market Revenue (USD Million), by Countries, 2024-2031
9.4.Latin America
9.4.1. Latin America Cannabidiol (CBD) API Market Revenue (USD Million) by Origin, (USD Million) 2024-2031
9.4.2. Latin America Cannabidiol (CBD) API Market Revenue (Million USD) by Product, (Million USD) 2024-2031
9.4.3. Latin America Cannabidiol (CBD) API Market Revenue (Million USD) by Indication, (Million USD) 2024-2031
9.4.4. Latin America Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast, by End User, 2024-2031
9.4.5. Latin America Cannabidiol (CBD) API Market Revenue (USD Million), by Countries, 2024-2031
9.5. middle east and africa
9.5.1. Middle East and Africa Cannabidiol (CBD) API Market Revenue (USD Million) by Origin, (USD Million) 2024-2031
9.5.2. Middle East and Africa Cannabidiol (CBD) API Market Revenue (USD Million) by Product, (USD Million) 2024-2031
9.5.3. Middle East and Africa Cannabidiol (CBD) API Market Revenue (USD Million) by Indication, (USD Million) 2024-2031
9.5.4. Middle East and Africa Cannabidiol (CBD) API Market Revenue (Million USD) Estimates and Forecast, by End User, 2024-2031
9.5.5.Middle East and Africa Cannabidiol (CBD) API Market Revenue by Countries (USD Million), 2024-2031
Chapter 10 Competitive Environment
10.1. Major mergers and acquisitions/strategic alliances
10.2.Company Profile
10.2.1. Recipharm
10.2.1.1. Business overview
10.2.1.2. Overview of main products/services
10.2.1.3. financial performance
10.2.1.4. geographical presence
10.2.1.5. Recent developments in business strategy
10.2.2. Brain
10.2.3. Presis
10.2.4.DSM
10.2.5. Bedrocan
10.2.6. Vantage Hemp
10.2.7. Eurofins
10.2.8. BioVectra Co., Ltd.
10.2.9. end pure
10.2.10. Bioside, UAB
10.2.11. KD Pharma Group
10.2.12. folium bioscience
10.2.13. kinetochem
10.2.14. colombian golden
10.2.15. Abelix Bio LLC
10.2.16. bellanova
10.2.17. KND Institute
10.2.18. jordan process
10.2.19. GVB Biopharma
10.2.20. other players
